Researchers have demonstrated the ability to generate dopaminergic neurons in the laboratory from induced pluripotent stem cells (iPSCs) derived from fibroblast cells of adult marmoset monkeys. This new study, documenting the iPSCs’ pluripotent properties and the potential for using this animal model to develop regenerative medicine approaches for dopamine-related disorders such as Parkinson’s disease, is published in Stem Cells and Development.